BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 22481868)

  • 1. Trypanosomatid comparative genomics: Contributions to the study of parasite biology and different parasitic diseases.
    Teixeira SM; de Paiva RM; Kangussu-Marcolino MM; Darocha WD
    Genet Mol Biol; 2012 Jan; 35(1):1-17. PubMed ID: 22481868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi.
    Parsons M; Worthey EA; Ward PN; Mottram JC
    BMC Genomics; 2005 Sep; 6():127. PubMed ID: 16164760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling the intracellular survival gene kit of trypanosomatid parasites.
    Bartholomeu DC; de Paiva RM; Mendes TA; DaRocha WD; Teixeira SM
    PLoS Pathog; 2014 Dec; 10(12):e1004399. PubMed ID: 25474314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
    Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology of kinetoplastid parasites: insights and challenges from genomics and post-genomics.
    Gull K
    Int J Parasitol; 2001 May; 31(5-6):443-52. PubMed ID: 11334928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Modelling of Platelet Activating Factor Acetyl Hydrolase in
    Goswami A; Koley T; Rajan MV; Madhuri P; Upadhyay N; Das U; Kumar M; Ethayathulla AS; Hariprasad G
    Infect Drug Resist; 2023; 16():2117-2128. PubMed ID: 37070125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of disease phenotype in trypanosomatid parasites.
    McCall LI; McKerrow JH
    Trends Parasitol; 2014 Jul; 30(7):342-9. PubMed ID: 24946952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching the Tritryp genomes for drug targets.
    Myler PJ
    Adv Exp Med Biol; 2008; 625():133-40. PubMed ID: 18365664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origins of amino acid transporter loci in trypanosomatid parasites.
    Jackson AP
    BMC Evol Biol; 2007 Feb; 7():26. PubMed ID: 17319943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory pathway of trypanosomatid parasites.
    McConville MJ; Mullin KA; Ilgoutz SC; Teasdale RD
    Microbiol Mol Biol Rev; 2002 Mar; 66(1):122-54; table of contents. PubMed ID: 11875130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp.
    Scarim CB; Chelucci RC; Dos Santos JL; Chin CM
    Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery.
    Bhattacharya A; Corbeil A; do Monte-Neto RL; Fernandez-Prada C
    Genes (Basel); 2020 Jun; 11(7):. PubMed ID: 32610603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era.
    Dumonteil E
    Infect Genet Evol; 2009 Dec; 9(6):1075-82. PubMed ID: 19805015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetoplastid Phylogenomics Reveals the Evolutionary Innovations Associated with the Origins of Parasitism.
    Jackson AP; Otto TD; Aslett M; Armstrong SD; Bringaud F; Schlacht A; Hartley C; Sanders M; Wastling JM; Dacks JB; Acosta-Serrano A; Field MC; Ginger ML; Berriman M
    Curr Biol; 2016 Jan; 26(2):161-172. PubMed ID: 26725202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Cartography Approaches to Study Trypanosomatid Infection.
    Dean DA; Haffner JJ; Katemauswa M; McCall LI
    J Vis Exp; 2022 Jan; (179):. PubMed ID: 35129167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression in trypanosomatid parasites.
    Martínez-Calvillo S; Vizuet-de-Rueda JC; Florencio-Martínez LE; Manning-Cela RG; Figueroa-Angulo EE
    J Biomed Biotechnol; 2010; 2010():525241. PubMed ID: 20169133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi specific mRNA amplification by in vitro transcription improves parasite transcriptomics in host-parasite RNA mixtures.
    Kessler RL; Pavoni DP; Krieger MA; Probst CM
    BMC Genomics; 2017 Oct; 18(1):793. PubMed ID: 29037144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative genome-wide study of ncRNAs in trypanosomatids.
    Doniger T; Katz R; Wachtel C; Michaeli S; Unger R
    BMC Genomics; 2010 Nov; 11():615. PubMed ID: 21050447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of non-LTR retrotransposons in the trypanosomatid genomes: Leishmania major has lost the active elements.
    Bringaud F; Ghedin E; Blandin G; Bartholomeu DC; Caler E; Levin MJ; Baltz T; El-Sayed NM
    Mol Biochem Parasitol; 2006 Feb; 145(2):158-70. PubMed ID: 16257065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State-of-the-art CRISPR/Cas9 Technology for Genome Editing in Trypanosomatids.
    Lander N; Chiurillo MA
    J Eukaryot Microbiol; 2019 Nov; 66(6):981-991. PubMed ID: 31211904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.